Time trade-off EQ-5D
Valuation of the EQ-5D-5L with composite time trade-off for the German population – an exploratory study
13
The responsiveness of the EQ-5D and time trade-off scores in schizophrenia, affective disorders, and alcohol addiction
9
<p>Minimally invasive lateral transiliac sacroiliac joint fusion using 3D-printed triangular titanium implants</p>
12
A uniform Time Trade Off method for states better and worse than dead: feasibility study of the ‘lead time’ approach
32
What is the value of social values? The uselessness of assessing health-related quality of life through preference measures
9
Future directions in valuing benefits for estimating QALYs: Is time up for the EQ-5D?
8
Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys
11
Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis
41
Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder
9
Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments
10
Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients
15
Study protocol for valuing EQ-5D-3L and EORTC-8D health states in a representative population sample in Sri Lanka
8
Ethnic differences in health related quality of life for patients with type 2 diabetes
10
The "Utility" Of The Time Trade-Off Method In Cancer Patiens: Feasibility And Proportional Trade-Off
8
EQ-5D-5L norms for the urban Chinese population in China
9
Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with somatoform disorders
12
Improving valuation sampling of EQ-5D health states
9
Level of agreement between patient-reported EQ-5D responses and EQ-5D responses mapped from the SF-12 in an injury population
8
Cross-cultural measurement equivalence of the 5-level EQ-5D (EQ-5D-5L) in patients with type 2 diabetes mellitus in Singapore
9
Using the EQ-5D as a performance measurement tool in the NHS
33